This is a preview of subscription content, log in via an institution to check access.
Reference
Zhang K, et al. Efficacy and safety of anlotinib in advanced non-small cell lung cancer: A real-world study. Cancer Management and Research 12: 3409-3417, 2020. Available from: URL: http://doi.org/10.2147/CMAR.S246000
Rights and permissions
About this article
Cite this article
Anlotinib. Reactions Weekly 1810, 28 (2020). https://doi.org/10.1007/s40278-020-80048-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80048-4